Sandu Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of Sandu Pharmaceuticals Ltd (SANDUPHQ) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads SANDUPHQ vs ZYDUSLIFE on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

23.91
P/E ratio
22.36
1.02
P/B ratio
4.09
2.70%
Dividend yield
0.08%
₹1.60
EPS
₹50.09

Profitability

ZYDUSLIFE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

4.13%
Return on equity
21.20%
5.47%
Return on capital
21.00%
4.11%
EBITDA margin
31.00%
2.31%
Net margin
18.87%

Growth

ZYDUSLIFE takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

1.03%
Revenue CAGR (3Y)
16.35%
1.72%
Profit CAGR (3Y)
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹37 Cr
Market cap
₹1.13L Cr
₹67 Cr
Revenue
₹27,148 Cr
₹2 Cr
Net profit
₹5,124 Cr
0.00
Debt / equity
0.31
Sandu Pharmaceuticals Ltd
  • + ["Company is almost debt free.", "Stock is trading at 0.85 times its book value", "Company's working capital requirements have reduced from 53.8 days to 42.0 days"]
  • ["The company has delivered a poor sales growth of 3.54% over past five years.", "Promoter holding is low: 37.8%", "Company has a low return on equity of 3.85% over last 3 years.", "Promoter holding has decreased over last 3 years: -14.6%"]
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
Sandu Pharmaceuticals Ltd full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.